Morgan HealthJPMorgan Chase’s healthcare business unit, announced that Dr. Cheryl Pegus will support the company’s strategic investments aimed at closing gaps in healthcare, working closely with Dan Hartman and Jeff Reis, who lead companies and the company’s investment efforts.
Pegus previously served as Executive Vice President for Health and Wellness at Walmart, where she helped launch consumer health programs, helped expand access to telehealth services and oversaw the COVID response. -19 from the company.
“Cheryl is one of the most respected leaders in healthcare and brings clinical and commercial healthcare expertise that will help accelerate the next phase of Morgan Health’s population health strategy. “, said Dan Mendelson, CEO of Morgan Health, in a press release.
“She is also a cardiologist and health equity expert and will play a vital role in our work investing and developing companies that are making a meaningful difference in reversing the tide of chronic disease, especially diabetes and heart disease, in the commercial market and recognizes the opportunity we have to improve health outcomes for our employees and the more than 150 million Americans who depend on employer-sponsored insurance.
In September, Morgan Health has announced that it has made a Strategic investment of $20 million in a home diagnostics startup and an Irish unicorn LetsGetChecked as part of a round of the D-2 series.
JP Morgan also invested $50 million in Vera Whole Health, a company aimed at providing coordinated primary care. Thanks to their partnership, with the participation of Central Ohio Primary Carethe companies opened three primary care centers for employees in Ohio and two nearby care centers for employees and their families.
Surgical training platform fundamental VR announced that it has expanded its leadership team with the appointments of Michelle Halsne, Erin Kullgren, Dottie Barrett and Maayan Wenderow.
Halsne will be vice president of sales, Kullgren vice president of growth. Barrett will serve as vice president of strategic data marketing and Wenderow will lead strategy and market execution.
Recent appointments mean that 55% of FundamentalVR’s leadership team is now made up of women.
“We are thrilled to welcome four amazing women to the FundamentalVR team and look forward to their contributions as we continue to grow in North America and Asia,” said Richard Vincent, co-founder and CEO of FundamentalVR, in a statement. communicated.
“Throughout 2022, we have continued to invest in our platform to transform the way surgical skills are learned in a scalable, low-cost, multi-user environment. Erin, Michelle, Maayan and Dottie will play a role essential to helping FundamentalVR achieve and better serve new customers that vision.”
The Massachusetts-based VR company announced that it had scored $20 million in Series B funding in August, led by EQT Life Sciences and joined by former investor Downing Ventures, bringing its total raised to over $30 million. He closed a 2019 $5 Million Series A Round.
Addiction treatment start-up Eleanor Health announced that it had hired Elizabeth Hart as head of customer and patient engagement, Scott Fries as chief financial officer and Peter Bird as chief of staff. Danica Patterson has also been promoted to Head of Markets.
The company, which offers in-person and virtual psychiatry, therapy, recovery coaching and medication treatment services for substance use disorders, said the new hires will support the company’s growth. and expanding its healthcare delivery model.
Hart joins Eleanor Health from direct primary care and mental health provider Everside Health, where she served as vice president of patient engagement.
Fries’ previous experience includes eight years as chief operating officer, executive vice president and senior vice president of experience at Allscripts and Prime Therapeutics, which followed Fries’ nine years as chief executive. finance at UnitedHealthcare and Optum.
Bird joins Eleanor Health from Carolina Complete Network, where he served as vice president of strategy and performance. As Chief of Staff at Eleanor, he will be responsible for board support, strategic planning processes, executive team cadences and certain strategic projects.
“We are excited to expand and enhance our leadership team,” said Corbin Petro, co-founder and CEO of Eleanor Health, in a statement. “This is an exciting time for all of us at Eleanor, as we continue to both improve the ability to deliver our transformative care model at scale effectively and sustainably, and succeed in partnerships based on the value and population.”
In April, Eleanor Health announced receipt of $50 million in Series C funding led by General Catalyst. Less than a year earlier, the hybrid mental health and addictions care startup had raised $20 million in Series B funding.
Ghaim joined the board on July 21 and Jain on October 7.
Ghaim is the founder and managing partner of Ignite Venture Studio, a company that helps grow digital health, wellness and beauty brands.
Jain is President and CEO of SCAN Group and Adjunct Professor of Medicine at Stanford. He was previously the CEO of CareMorea chronic disease management company, and Aspire Health, which provides in-home and virtual palliative care services.
“On behalf of the management team and the board, I am delighted to welcome Josh and Sachin to the Cue team. We are delighted to have a broad knowledge of health plans and payers as well as perspective from a Cue board physician as we continue to pursue our vision of making healthcare more convenient, accessible and timely by placing diagnostic information at the center of care,” said Ayub Khattak, president and CEO of Cue Health.
Cue, best known for its at-home COVID-19 molecular test, made public in 2021 with a $200 million IPO.
In June of this year, the diagnostics company announced that it had laid off 170 manufacturing workers due to considerable economic challenges and the federal government’s decision to divert funding for COVID-19 testing.